OSTEOPORE LIMITED

INVESTOR PRESENTATION - OSTEOPORE LIMITED

ASX:OSX

OSTEOPORE LIMITED

Health Care

Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.

Read more

Market Cap

38.13m

Price at Close

$0.615

4w avg. Volume

187.27k

4w avg. Turnover

$123.94k

Announcements
announcementt+2 movementdate
  • Amended Activities Update Qtr Ending June 2020 and App 4C

    Commitments test entity quarterly reports

  • -6.25%

    31 Jul 2020

-6.25%

31 Jul 2020
  • Activities Update Quarter Ending June 2020 and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • -6.25%

    31 Jul 2020

-6.25%

31 Jul 2020
  • Development of New 3D Printed Bone Implant

    Progress Report · Market sensitive

  • -3.88%

    22 Jul 2020

-3.88%

22 Jul 2020
  • Clarification on Initial US Distribution Agreement

    Progress Report · Market sensitive

  • -21.56%

    02 Jul 2020

-21.56%

02 Jul 2020
  • Pause In Trading

    Stock Exchange Announcement · Market sensitive

  • -21.56%

    02 Jul 2020

-21.56%

02 Jul 2020
  • Osteopore Signs Initial U.S. Distribution Agreement

    Progress Report · Market sensitive

  • +63.75%

    01 Jul 2020

+63.75%

01 Jul 2020
  • Appendix 2A

    Issued Capital

  • -4.44%

    23 Jun 2020

-4.44%

23 Jun 2020
  • Notice of Release from Escrow

    Issued Capital

  • -8.99%

    11 Jun 2020

-8.99%

11 Jun 2020
  • Constitution

    Company Administration

  • -8.99%

    11 Jun 2020

-8.99%

11 Jun 2020
  • Results of Annual General Meeting

    Notice Of Meeting

  • -5.94%

    05 Jun 2020

-5.94%

05 Jun 2020
Market Data

Current Price

$0.615

52WK HIGH

$1.49

52WK LOW

$0.275

1YR RETURN

-15.17%

1YR RETURN VS. SECTOR

-47.77%

90 DAY RETURN

+24.24%

ASX RANK

1,106

/2,032

SECTOR RANK

5

/8

SHARES OUTSTANDING

62.00m
ASX:OSX

OSTEOPORE LIMITED

Health Care

Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.

Read more

Market Cap

38.13m

Price at Close

$0.615

4w avg. Volume

187.27k

4w avg. Turnover

$123.94k

ASX:OSX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

(03) 9028 2888

deals@freshequities.com

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.